The tweet was deleted by the author.
But we saved everything 🙂.
Quantum-Si announced live developments in next-generation protein sequencing at the AACR conference, with Dr. Nigel O'Neil, founder and CSO of Arrowsmith Genetics, presenting strategies for identifying novel cancer treatments.
Attendees are invited to engage further at the event's poster session and booth 4257, where the application of cutting-edge protein sequencing in cancer research is being discussed.
View post on X Loading...
Quantum-Si recently introduced single molecule sequencing to enhance post-translational modification detection in protein analysis workflows. The company also unveiled a protein sequencing platform capable of single-amino-acid resolution from nanogram-scale samples. Both advances point to growing interest in high-resolution protein sequencing applications in cancer research.